Winners of 2019 Innovations in Regulatory Science Awards Announced

FDA’s Theresa Mullin, Compassionate Use Advisory Committee, and Cystic Fibrosis Foundation to be Honored with Innovations in Regulatory Science Awards 

Honorees to be recognized on December 11 in Washington, DC

Washington, DC - The Reagan-Udall Foundation for the FDA will present 2019 Innovations in Regulatory Science Awards to Theresa M. Mullin, PhD, of the FDA’s Center for Drug Evaluation and Research; the Compassionate Use Advisory Committee, a collaborative program of Johnson & Johnson and New York University; and the Cystic Fibrosis Foundation.

 


About the Reagan-Udall Foundation for the FDA

The Reagan-Udall Foundation for the FDA (FDA Foundation) is an independent 501(c)(3) created by Congress to advance regulatory science to help the U.S. Food and Drug Administration accomplish its mission. The FDA Foundation works to improve health and safety through stakeholder engagement and public-private partnerships that facilitate innovation, foster the use of real-world evidence, and identify modern tools and polices to keep pace with today’s rapidly evolving science.

Media Contacts:

Lea Ann Browning-McNee
301-509-1846 (cell)
Lmcnee@reaganudall.org  

Mary McNamara
202-276-7822 (cell)
mmcnamara@reaganudall.org